ArticleOpen forum infectious diseases2025

Learning From Full Characterization of HIV Proviruses in People Receiving Long-Acting Cabotegravir/Rilpivirine With a History of Replication on the Antiretroviral Classes.

Gilbert Mchantaf et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.